- Palabras clave > access - existing and new antimicrobial medicines and diagnostic tools
- Palabras clave > antibacterial resistance (ABR)
- Palabras clave > antibiotic resistance
- Palabras clave > antimicrobial resistance (AMR)
- Palabras clave > antimicrobial resistance surveillance
- Palabras clave > containment of antimicrobial resistance
- Palabras clave > drug resistance, microbial
- Palabras clave > new medicines
- Palabras clave > pharmaceutical research and development (R&D)
- Palabras clave > surveillance - antibiotic resistance and antibiotic use
- Palabras clave > confinement antimicrobien
(2019; 95 pages)
Antimicrobials have saved hundreds of millions of lives and substantially contributed to development and economic growth. However, they are now losing their power because of the microorganisms’ acquired capacity to withstand the drugs designed to kill them, to inactivate or slow their growth: antimicrobial resistance (AMR).
Unchecked, AMR could severely reduce global economic output and hobble human and sustainable development progress in the decades ahead. AMR is a development issue.
The report shows that we are facing a major gap between “knowing” and “doing.” Abundant knowledge exists about many aspects of AMR, yet people do not seem to know what to do, or how to do it. This calls for major efforts to be made in the field of implementation research to bridge knowledge and actions in real-world settings.
AMR-sensitive interventions can be designed and delivered in such a way that they contribute cobenefits in addressing AMR. In building roads, ports and other urban developments, as well as through interventions to build health systems, improve animal husbandry, or improve water and sanitation, there are opportunities to maximize impact on AMR.